Nationwide Fund Advisors Sells 4,547 Shares of Cooper Companies, Inc. (The) (COO)

Nationwide Fund Advisors cut its holdings in Cooper Companies, Inc. (The) (NYSE:COO) by 4.3% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 100,853 shares of the medical device company’s stock after selling 4,547 shares during the quarter. Nationwide Fund Advisors owned about 0.21% of Cooper Companies, Inc. (The) worth $24,146,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. BlackRock Inc. raised its holdings in Cooper Companies, Inc. (The) by 2,849.1% in the first quarter. BlackRock Inc. now owns 3,071,637 shares of the medical device company’s stock worth $613,991,000 after purchasing an additional 2,967,481 shares during the period. Pioneer Investment Management Inc. raised its holdings in Cooper Companies, Inc. (The) by 136.6% in the second quarter. Pioneer Investment Management Inc. now owns 1,226,250 shares of the medical device company’s stock worth $293,589,000 after purchasing an additional 708,028 shares during the period. Janus Capital Management LLC raised its holdings in Cooper Companies, Inc. (The) by 35.7% in the first quarter. Janus Capital Management LLC now owns 1,743,182 shares of the medical device company’s stock worth $348,441,000 after purchasing an additional 458,173 shares during the period. Los Angeles Capital Management & Equity Research Inc. acquired a new stake in Cooper Companies, Inc. (The) in the second quarter worth $71,050,000. Finally, Findlay Park Partners LLP acquired a new stake in Cooper Companies, Inc. (The) in the first quarter worth $55,664,000. 95.92% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: This story was first published by Transcript Daily and is owned by of Transcript Daily. If you are reading this story on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this story can be viewed at https://transcriptdaily.com/2017/09/17/nationwide-fund-advisors-sells-4547-shares-of-cooper-companies-inc-the-coo.html.

Several research firms have weighed in on COO. Oppenheimer Holdings, Inc. set a $225.00 target price on shares of Cooper Companies, Inc. (The) and gave the stock a “hold” rating in a report on Saturday, June 3rd. Jefferies Group LLC set a $250.00 target price on shares of Cooper Companies, Inc. (The) and gave the stock a “buy” rating in a report on Thursday, August 17th. Robert W. Baird reiterated a “buy” rating and issued a $273.00 target price (up from $267.00) on shares of Cooper Companies, Inc. (The) in a report on Tuesday, September 12th. Cleveland Research reiterated a “buy” rating on shares of Cooper Companies, Inc. (The) in a report on Tuesday, August 22nd. Finally, J P Morgan Chase & Co reiterated a “hold” rating and issued a $235.00 target price on shares of Cooper Companies, Inc. (The) in a report on Tuesday, September 12th. Six analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $257.60.

Shares of Cooper Companies, Inc. (NYSE COO) opened at 245.21 on Friday. The company’s 50 day moving average is $245.23 and its 200-day moving average is $224.59. The firm has a market capitalization of $11.98 billion, a price-to-earnings ratio of 36.76 and a beta of 0.59. Cooper Companies, Inc. has a one year low of $158.73 and a one year high of $256.39.

Cooper Companies, Inc. (The) (NYSE:COO) last issued its earnings results on Thursday, August 31st. The medical device company reported $2.64 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.58 by $0.06. The business had revenue of $556.00 million for the quarter, compared to analyst estimates of $552.32 million. Cooper Companies, Inc. (The) had a net margin of 16.45% and a return on equity of 16.00%. Cooper Companies, Inc. (The)’s revenue was up 8.0% on a year-over-year basis. During the same period in the prior year, the firm earned $2.30 earnings per share. Equities analysts expect that Cooper Companies, Inc. will post $9.72 EPS for the current year.

In related news, VP Randal Golden sold 1,621 shares of the stock in a transaction on Tuesday, July 11th. The shares were sold at an average price of $243.65, for a total transaction of $394,956.65. Following the transaction, the vice president now directly owns 1,731 shares of the company’s stock, valued at $421,758.15. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, COO Daniel G. Mcbride sold 6,000 shares of the stock in a transaction on Wednesday, June 21st. The stock was sold at an average price of $244.23, for a total transaction of $1,465,380.00. Following the transaction, the chief operating officer now directly owns 34,395 shares in the company, valued at $8,400,290.85. The disclosure for this sale can be found here. Over the last three months, insiders have sold 20,992 shares of company stock worth $5,167,628. 1.60% of the stock is owned by insiders.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies, Inc. (The) (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply